An unusual case of blackwater fever
Dear Editor, A 32-year-old gentleman admitted with high-grade intermittent fever associated with chills, headache and fatigue for 2 days and passage of dark urine for last 6 hours. He had no past history of malaria, and he denied intake of any medicine immediately before this presentation. He had an axillary temperature of 103.6°F, severe pallor, mild icterus, hepatosplenomegaly and coca-cola coloured urine [ Figure 1 ]. Peripheral capillary-blood smear (PBS) showed ring forms of Plasmodium falciparum (28,312 parasites/μl). Haemoglobin and haematocrit levels were 6.4 g/dl and 20.3%, respectively, with normal glucose-6-phosphate-dehydrogenase activity (G6PD). Urine examination was positive for HAEM-test in the absence of red blood cells suggestive of haemoglobinuria. Renal and liver function tests were also deranged. He was managed with intravenous artesunate, crystalloids and packed-red-blood-cell. The PBS became negative for parasite after 48 h, urine colour normalised by day-3.
Blackwater fever (BWF), a rarely encountered clinical entity, is known to occur predominantly in nonimmune individuals residing in P. falciparum-endemic areas and receiving inadequate doses of the anti-malarial drug quinine. [1] This medical emergency is characterised by sudden and severe intravascular haemolysis leading to haemoglobinaemia and haemoglobinuria and clinically manifested by anaemia, passage of dark urine and often oliguric renal failure. [2] Though the underlying pathogenesis is poorly understood, association with partial immunity to malaria, G6PD-deficiency with subsequent oxidative-drug exposure, use of amino-alcohols particularly quinine and severe falciparum malaria with normal G6PD levels have been documented. [3] PBS usually documents low levels or absence of P. falciparum parasitaemia, as they are destroyed by the haemolytic crisis like in this case. [1] Strong clinical suspicion is the cornerstone of early diagnosis and management to reduce mortality and morbidity.
This was a rare scenario in which BWF developed on the first malarial episode in an adult patient from endemic zone who are unlikely to develop severe life-threatening malaria (unless they leave the transmission area and return years later) [4] without underlying G6PD deficiency or use of culprit medications.
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There are no conflicts of interest. Dear Editor, Burkholderia cepacia complex (BCC) causes infections that are proving difficult to treat because of both high intrinsic (aminoglycosides and colistin) and acquired resistance (β lactams) and also occasionally to co-trimoxazole (the drug of choice). [1] [2] [3] We are describing a rare case of spontaneous septic arthritis by BCC in a pre-term infant.
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A 3-month-old pre-term intrauterine growth retarded (IUGR), female infant (2.02 kg) was admitted to the neonatology intensive care unit for the paucity of movements in both legs for 3 days and failure to thrive. This was not associated with fever or trauma. There was no history of decreased intake of feeds/lethargy/irritability. On examination, she was alert with restricted movements of both limbs. The heart rate was 110/min and respiratory rate was 36/min, SPO 2 97% at room temperature.
Investigations
revealed elevated C-reactive protein (CRP) -27.9 mg/L, white blood cell count -14,500 cells/mm 3 (lymphocytes -70%), red blood cell count -4.8 millions/mm 3 and hemoglobin -11.5 g%. Ultrasonography (USG) hip showed a bilateral collection of minimal intracapsular fluid with internal echos. USG of abdomen and brain were normal. Blood and cerebrospinal fluid cultures showed no growth.
Spontaneous septic arthritis due to Burkholderia cepacia in a 3-month-old pre-term infant
Aspirate loaded onto BacT/ALERT PF Plus bottle yielded growth of B. cepacia [ Figure 1 ], which was sensitive to ceftazidime (MIC 2), levofloxacin (MIC 1), minocycline (MIC ≤1), meropenem (MIC 1) and cotrimoxazole (MIC ≤20) (VITEK-2). The infant
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